Royalty Pharma to release Q3 2026 earnings on Nov 4 with live webcast and call.

Royalty Pharma plc announced it will report its third quarter 2026 financial results on November 4, 2026, before U.S. markets open. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss the results. Royalty Pharma is a major buyer of biopharmaceutical royalties and funds innovation in the industry, with a portfolio including royalties on over 35 commercial products and 17 development-stage candidates. Investors can access the call details and replay on the company's website.

Royalty Pharma is set to release its Q3 2026 financial results on November 4, 2026, a key date for investors following its performance. On Pluang, Royalty Pharma's Class A shares trade at USD 56.20 as of October 9, 2026, 20:02 WIB, showing a slight 0.03% decline in the past day. The stock holds a market capitalization of $25.27 billion and maintains a dividend yield of 1.66%, with all recent Pluang orders being buys, indicating steady investor interest.